TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $765,000 | -50.6% | 41,904 | -50.8% | 0.00% | -50.0% |
| Q4 2020 | $1,549,000 | -19.6% | 85,088 | -21.2% | 0.01% | -33.3% |
| Q3 2020 | $1,927,000 | -48.0% | 108,028 | -47.7% | 0.01% | -53.8% |
| Q2 2020 | $3,707,000 | +186.9% | 206,752 | +143.0% | 0.03% | +100.0% |
| Q1 2020 | $1,292,000 | -65.9% | 85,088 | -55.7% | 0.01% | -50.0% |
| Q4 2019 | $3,786,000 | -89.3% | 191,879 | -90.7% | 0.03% | -90.7% |
| Q3 2019 | $35,428,000 | -3.7% | 2,059,728 | -0.9% | 0.28% | -7.9% |
| Q2 2019 | $36,799,000 | -69.5% | 2,079,070 | -64.9% | 0.30% | -46.8% |
| Q1 2019 | $120,762,000 | – | 5,928,414 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |